SAN FRANCISCO, Oct. 16, 2019 /PRNewswire/ -- Goldman Sachs is
recognizing Sempre Health's founder and CEO Anurati Mathur as one of the 100 Most Intriguing
Entrepreneurs of 2019 at its Builders + Innovators Summit in
Santa Barbara, Calif. Goldman
Sachs selected Mathur as one of 100 entrepreneurs from multiple
industries to be honored at the three-day event.
Drug costs are one of the main reasons why roughly half of
all Americans with chronic health conditions do not take their
medications as prescribed. Failing to refill prescriptions has been
shown to cause health complications that cost the U.S.
healthcare system between $100
billion and $300 billion per
year, leading to more than 100,000 preventable deaths
annually.
Sempre Health is the first company with the right mix of
technology, behavioral science and business model to help people
afford and take their medications. Unlike traditional coupons,
Sempre redistributes dollars that are already earmarked for patient
assistance to offer dynamic pricing discounts to patients who
refill prescriptions as directed by their physician. This enables
consumers to benefit from the same cost savings that insurers, care
providers and pharmaceutical companies experience when people make
responsible health decisions.
The company operates a two-sided marketplace. On one side,
manufacturers add their chronic disease medications and their
budget. On the other side, health plans select medications for
which to offer members dynamically priced discounts. For the
member, the program is reminiscent of the "good driver discounts"
offered by auto insurance companies. Sempre Health works with
leading payers like Blue Cross Blue Shield of Arizona and UPMC, as well as many of the
country's top pharmaceutical companies.
"Sempre Health brings the first dynamic pricing to the pharmacy,
giving consumers the power to lower what they pay for medications
by simply following doctors' orders," said Mathur. "These discounts
grow over time with continued adherence, which increases alignment
between pharmacies, consumers, payers and pharmaceutical companies.
Sempre Health serves as a bridge between these stakeholders,
enabling a long-term relationship built on trust."
Government researchers have conclusively linked medication
adherence to a drop in adverse health events and preventable death.
Based on experience to date, Sempre Health has seen its dynamic
discounts significantly boost medication adherence. The company
plans to submit its data and research for peer review.
"True innovation is built from a diversity of perspectives and
experiences," said David M. Solomon,
chief executive officer of Goldman Sachs. "Our Builders +
Innovators Summit brings together a collective of impressive future
leaders who are striving to drive meaningful change. For 150 years,
Goldman Sachs has supported entrepreneurs as they launch and grow
their businesses. That's why we are pleased to recognize
Anurati Mathur as one of the most
intriguing entrepreneurs of 2019."
In addition to honoring 100 entrepreneurs, the summit consists
of general sessions and clinics led by seasoned entrepreneurs,
academics and business leaders as well as resident scholars.
About Sempre Health
Sempre Health is the first company
with the right mix of technology, behavioral science and business
model to help people afford and take their medications. Sempre
Health aims to boost all of its members' medication adherence to
meet or exceed 80 percent -- the widely acknowledged gold standard.
Doing so will dramatically improve the health of millions of people
and save hundreds of billions of dollars in avoidable medical
costs. For more information visit: www.semprehealth.com.
Media Contact
Sempre Health
press@semprehealth.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/sempre-health-honored-by-goldman-sachs-for-entrepreneurship-300940109.html
SOURCE Sempre Health